Jonathan G. Drachman - Dec 31, 2021 Form 5 Insider Report for Neoleukin Therapeutics, Inc. (NLTX)

Role
President and CEO, Director
Signature
/s/ Robert Ho, as Attorney-in-Fact for Jonathan Drachman
Stock symbol
NLTX
Transactions as of
Dec 31, 2021
Transactions value $
$0
Form type
5
Date filed
2/14/2022, 06:54 PM
Previous filing
Nov 10, 2021
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NLTX Common Stock Gift $0 -75K -3.3% $0.00 2.2M Oct 26, 2021 Direct
transaction NLTX Common Stock Gift $0 -75K -3.3% $0.00 2.2M Oct 26, 2021 Direct
transaction NLTX Common Stock Gift $0 +75K +300% $0.00 100K Oct 26, 2021 See footnote F1
transaction NLTX Common Stock Gift $0 +75K +300% $0.00 100K Oct 26, 2021 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by the PLD Family Trust 2020.
F2 These securities are held by the JGD Family Trust 2020.